Cell Penetrating Peptides: The Molecular Taxis That Deliver Drugs Inside Cells
Cell penetrating peptides are short protein fragments that can cross cell membranes, acting as delivery vehicles to carry drugs, genes, proteins, and nanoparticles into cells that they couldn't otherwise enter.
Quick Facts
What This Study Found
Cell penetrating peptides (CPPs) are short peptide sequences that can cross cell membranes — a feat that most therapeutic molecules cannot accomplish. This review classifies CPPs into categories based on their origin and properties, describes their uptake mechanisms (direct penetration vs. endocytosis), and catalogs their biomedical applications as delivery vehicles for nucleic acids, proteins, siRNA, drugs, and nanoparticles.
The key insight is that CPPs can carry virtually any type of therapeutic cargo across cell membranes, making them one of the most versatile drug delivery tools in biomedical research.
Key Numbers
Review covering 20+ years of CPP research · cargo types: nucleic acids, proteins, siRNA, drugs, nanoparticles · multiple CPP classes and uptake mechanisms reviewed
How They Did This
Narrative review synthesizing the CPP literature. The authors describe CPP classification schemes (cationic, amphipathic, hydrophobic), uptake mechanisms (direct penetration, endocytosis-dependent pathways), and biomedical applications across drug delivery, gene therapy, and diagnostic imaging.
Why This Research Matters
Getting drugs inside cells is one of the biggest challenges in medicine. Many promising therapeutics — gene therapies, siRNA, proteins — can't cross cell membranes to reach their targets. CPPs solve this problem by acting as molecular taxis, ferrying cargo through the membrane barrier. This technology underpins a wide range of emerging therapies from cancer treatment to gene editing.
The Bigger Picture
CPPs are a foundational technology in modern drug delivery. As medicine moves toward increasingly sophisticated intracellular therapies — gene editing, mRNA therapeutics, targeted protein degradation — the ability to get these tools inside cells becomes critical. CPPs represent one of the most promising solutions, and understanding their biology is essential for anyone working in pharmaceutical development or biomedical engineering.
What This Study Doesn't Tell Us
As a concise review, it doesn't cover all CPPs or applications exhaustively. The review primarily describes in vitro and preclinical evidence — few CPP-based therapeutics have reached clinical approval. Endosomal entrapment (where cargo gets stuck after uptake) is a major unresolved challenge that is not deeply explored. The review is from 2018 and doesn't capture more recent developments.
Questions This Raises
- ?How can the endosomal escape problem be solved to improve the efficiency of CPP-mediated delivery?
- ?Can CPPs be engineered to target specific cell types rather than entering all cells indiscriminately?
- ?What safety concerns arise from widespread cellular penetration in a therapeutic context?
Trust & Context
- Key Stat:
- Versatile intracellular delivery vehicles CPPs can transport nucleic acids, proteins, siRNA, small molecule drugs, and nanoparticles across cell membranes — making them one of the most adaptable delivery tools in biomedical research
- Evidence Grade:
- This is a well-cited review covering an established field of research. The existence and utility of CPPs is well-proven in vitro and in animal models. However, clinical translation remains limited, and the review doesn't present new data. Moderate evidence for the field overall.
- Study Age:
- Published in 2018. The CPP field has continued to advance, with improvements in endosomal escape, cell-specific targeting, and clinical translation. The fundamental concepts described remain accurate and relevant.
- Original Title:
- Cell penetrating peptides: A concise review with emphasis on biomedical applications.
- Published In:
- Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 108, 1090-1096 (2018)
- Authors:
- Derakhshankhah, Hossein, Jafari, Samira
- Database ID:
- RPEP-03645
Evidence Hierarchy
Frequently Asked Questions
What are cell penetrating peptides made of?
CPPs are typically short chains of 5–30 amino acids. Many are rich in positively charged amino acids like arginine and lysine, which help them interact with the negatively charged cell membrane. Some are derived from natural proteins (like the HIV-1 TAT protein), while others are designed synthetically.
Why can't most drugs get inside cells on their own?
Cell membranes are made of lipids that block most large, charged, or water-soluble molecules from crossing. This is essential for cell survival but creates a major challenge for delivering therapeutic molecules — especially large ones like proteins, DNA, or RNA — to intracellular targets. CPPs overcome this barrier.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-03645APA
Derakhshankhah, Hossein; Jafari, Samira. (2018). Cell penetrating peptides: A concise review with emphasis on biomedical applications.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 108, 1090-1096. https://doi.org/10.1016/j.biopha.2018.09.097
MLA
Derakhshankhah, Hossein, et al. "Cell penetrating peptides: A concise review with emphasis on biomedical applications.." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018. https://doi.org/10.1016/j.biopha.2018.09.097
RethinkPeptides
RethinkPeptides Research Database. "Cell penetrating peptides: A concise review with emphasis on..." RPEP-03645. Retrieved from https://rethinkpeptides.com/research/derakhshankhah-2018-cell-penetrating-peptides-a
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.